Figure 2From: Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison Kaplan-Meier estimate of overall survival according to type of chemotherapy associated with trastuzumab. The solid line represents patients receiving docetaxel and the dashed line those receiving vinorelbine.Back to article page